Published in Bull Math Biol on June 12, 2017
The hallmarks of cancer. Cell (2000) 113.05
Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw (2010) 38.65
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev (1998) 12.55
Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol (2002) 9.17
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (1993) 6.84
A single type of progenitor cell maintains normal epidermis. Nature (2007) 6.32
The E2F1-3 transcription factors are essential for cellular proliferation. Nature (2001) 4.37
Natural history of genital warts. Br J Vener Dis (1971) 4.22
Epidemiology of genital human papillomavirus infection. Am J Med (1997) 4.09
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med (2007) 3.88
Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) (2006) 3.74
Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol (2000) 3.22
Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis (2007) 2.93
A bistable Rb-E2F switch underlies the restriction point. Nat Cell Biol (2008) 2.91
Animal transcription networks as highly connected, quantitative continua. Dev Cell (2011) 2.87
Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A (2000) 2.84
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev (1997) 2.83
Proteasome inhibitors in multiple myeloma: 10 years later. Blood (2012) 2.77
Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes. J Biol Chem (2006) 2.73
Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc Natl Acad Sci U S A (1985) 2.65
Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J (1996) 2.61
Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56
The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev (2003) 2.52
Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol (1993) 2.37
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature (2009) 2.22
Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol (2013) 2.17
Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health (2010) 2.14
Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci U S A (1992) 2.10
Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol (2000) 2.00
Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96
Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog (2009) 1.94
A model for restriction point control of the mammalian cell cycle. J Theor Biol (2004) 1.86
Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol (2007) 1.73
Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev (2002) 1.70
The natural history of human papillomavirus infections of the mucosal epithelia. APMIS (2010) 1.61
Processive phosphorylation of ERK MAP kinase in mammalian cells. Proc Natl Acad Sci U S A (2011) 1.55
The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell Div (2012) 1.46
Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe (2014) 1.42
The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol (1993) 1.35
Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev (2012) 1.33
Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. Proc Natl Acad Sci U S A (2012) 1.33
Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. Elife (2014) 1.26
Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. J Virol (2014) 1.26
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology (2012) 1.23
Functional studies of E7 proteins from different HPV types. Oncogene (1994) 1.22
Screening for cervical cancer: should we test for infection with high-risk HPV? CMAJ (2000) 1.21
Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol (2016) 1.20
Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest. J Virol (2001) 1.12
Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives. Cancer Epidemiol Biomarkers Prev (2007) 1.11
PP2A-mediated regulation of Ras signaling in G2 is essential for stable quiescence and normal G1 length. Mol Cell (2014) 0.92
Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding. Biochim Biophys Acta (2004) 0.90
Pathogenesis of human papillomavirus-associated mucosal disease. J Pathol (2015) 0.89
A Dynamical Framework for the All-or-None G1/S Transition. Cell Syst (2016) 0.88
Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target. J Mol Biol (2011) 0.87
The prevalence of "high-risk" HPV types in penile condyloma-like lesions: correlation between HPV type and morphology. Genitourin Med (1993) 0.85
Revising ecological assumptions about Human papillomavirus interactions and type replacement. J Theor Biol (2014) 0.84
Differential cell cycle regulation by low- and high-risk human papillomaviruses in low-grade squamous intraepithelial lesions of the cervix. Cancer Res (1998) 0.80
The ecology of human papillomavirus-induced epithelial lesions and the role of somatic evolution in their progression. J Infect Dis (2013) 0.78
The Dynamics of HPV Infection and Cervical Cancer Cells. Bull Math Biol (2015) 0.78
HPV clearance and the neglected role of stochasticity. PLoS Comput Biol (2015) 0.78
Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer. J Clin Med (2015) 0.76
The Low-Risk Papillomaviruses. Virus Res (2016) 0.76
Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa. PLoS One (2017) 0.75